Comparison of comorbidities between SSc-SLE and SSc subjects.
| Comorbidities | SSc, n (%) | SSc-SLE overlap, n (%) | SMD*, % |
|---|---|---|---|
| Coronary artery disease | 104 (9) | 3 (4) | 23 |
| Hypertension | 244 (21) | 16 (19) | 6 |
| Diabetes mellitus | 66 (6) | 5 (6) | 0.7 |
| Dyslipidemia | 84 (7) | 4 (5) | 11 |
| Peripheral vascular disease | 46 (4) | 4 (5) | 3 |
| Cancer | 128 (11) | 6 (7) | 14 |
| Stroke | 30 (3) | 2 (2) | 2 |
| Atrial fibrillation | 47 (4) | 4 (5) | 3 |
↵* SMD > 25% is considered a meaningful difference between groups. SSc: systemic sclerosis; SLE: systemic lupus erythematosus; SMD: standardized mean difference.